Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,42 USD | 0,00% | -5,79% | -20,28% |
03/04 | SUTRO BIOPHARMA, INC. : Piper Sandler herhaalt koopadvies voor het aandeel | ZM |
03/04 | SUTRO BIOPHARMA, INC. : Truist Securities handhaaft koopadvies | ZM |
Vakgebied
Aantal werknemers: 302
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 14-01-09 |
Jane Chung
PSD | President | 53 | 09-08-21 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 31-01-13 |
Steve Michel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-20 |
Chief Tech/Sci/R&D Officer | - | 18-09-23 | |
Henry Heinsohn
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Borgman
CTO | Chief Tech/Sci/R&D Officer | 56 | 28-02-23 |
Public Communications Contact | 67 | 01-01-08 | |
Werner Rubas
PRN | Corporate Officer/Principal | - | 16-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 24-06-19 |
James Panek
BRD | Director/Board Member | 71 | 07-01-20 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
John Freund
BRD | Director/Board Member | 70 | 01-02-14 |
Joseph Lobacki
BRD | Director/Board Member | 65 | 01-02-17 |
William Newell
CEO | Chief Executive Officer | 66 | 14-01-09 |
Michael Dybbs
BRD | Director/Board Member | 49 | 25-07-18 |
Heidi Hunter
BRD | Director/Board Member | 66 | 19-11-21 |
Jon Wigginton
BRD | Director/Board Member | 62 | 30-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 75 488 593 | 74 756 129 ( 99,03 %) | 0 | 99,03 % |
Bedrijfsgegevens
Sutro Biopharma, Inc.
111 Oyster Point Boulevard
94080, South San Francisco
+650 881 6500
http://www.sutrobio.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,28% | 280 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers STRO
- Onderneming Sutro Biopharma, Inc.